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Abstract 
 
The nsP2 protease of chikungunya virus (CHIKV) is one of the essential components of viral 
replication and it plays a crucial role in the cleavage of polyprotein precursors for the viral 
replication process. Therefore, it is gaining attention as a potential drug design target against 
CHIKV. Based on the recently determined crystal structure of the nsP2 protease of CHIKV, this 
study identified potential inhibitors of the virus using structure-based approaches with a 
combination of molecular docking, virtual screening and molecular dynamics (MD) simulations. 
The top hit compounds from database searching, using the NCI Diversity Set II, with targeting at 
five potential binding sites of the nsP2 protease, were identified by blind dockings and focused 
dockings. These complexes were then subjected to MD simulations to investigate the stability and 
flexibility of the complexes and to gain a more detailed insight into the interactions between the 
compounds and the enzyme. The hydrogen bonds and hydrophobic contacts were characterized for 
the complexes. Through structural alignment, the catalytic residues Cys1013 and His1083 were 
identified in the N-terminal region of the nsP2 protease. The absolute binding free energies were 
estimated by the linear interaction energy approach and compared with the binding affinities 
predicted with docking. The results provide valuable information for the development of inhibitors 
for CHIKV. 
 
Keywords: nsP2 protease, chikungunya virus, structure-based approaches, molecular docking, 
virtual screening, molecular dynamics simulations. 
 
 
 
 
 
 
 
 
2 
 
1. Introduction 
 
Chikungunya disease is caused by the chikungunya virus (CHIKV) which is one of the neglected 
tropical diseases that has emerged [1, 2] or reemerged [3-5] in recent years. This virus is transmitted 
from human to human by the bite of Aedes aegpti and Aedes albopictus mosquitoes [6]. The virus 
was first recorded in Tanganyiaka, Africa in 1952 [7] with the name chikungunya derived from the 
local dialect, meaning “that which bends up” [7] literally describing the stooped posture of patients 
who have to suffer joint pains for weeks or even years [7, 8]. The virus has been largely neglected 
due to its sporadic reemergence [3, 9], but it has recently gained attention with epidemics occurring 
since 2006 in nearly 40 different countries [10] from Africa to Asia, Europe, US and Australia 
spread by infected travellers. Even though the chikungunya disease is non-fatal, its characteristic 
symptoms include high fever, rash, headache, arthralgia, myalgia and polyarthralgia which affects 
patients, and results in significant health problems worldwide [9-13]. Unfortunately, there are no 
effective drugs or specific treatments available [10]. 
 
CHIKV belongs to the Alphavirus genus in the Togaviridae family [2]. Like other alphavirus, 
CHIKV attaches to the host through receptor-mediated endocytosis depending on endosome 
acidification [14]. The complete genome of CHIKV was determined in 2002 and has a length of 
11,805 nucleotides [15]. It consists of two open reading frames (ORFs) [12, 15] with the first ORF 
encoding four non-structural proteins (nsP), namely nsP1, nsP2, nsP3 and nsP4 and the second ORF 
encoding structural proteins including the capsid (C), envelope glycoproteins E1 and E2 and two 
small cleavage products (E3 and 6K). The envelope glycoproteins are involved with viral entry 
while the non-structural proteins are essential components and play a crucial role in viral replication 
and transcription [10, 16]. Therefore, they are considered as potential targets which several studies 
utilized to identify potential inhibitors against CHIKV [10, 17-22].  
 
Among the non-structural proteins, the nsP2 protein is an attractive target. This protein is a 
multifunctional enzyme [10, 16]. In its free form, the protein induces cytotoxicity and is responsible 
for transcriptional shut-off [2]. The complete nucleotide sequence of the CHIKV genome revealed 
that the nsP2 protein is the largest non-structural protein, being 798 amino acids long and 
possessing a large net positive charge [15]. In the N-terminal domain, there are functions of 
nucleoside triphosphatase, helicase, and RNA-dependent 5΄-triphosphatase while “activities of 
cysteine protease”, also known as thiol protease, are present in the C-terminal domain (the nsP2 
protease) [2, 16]. The proteolytic activity of the nsP2 protein plays an important role in the cleavage 
of non-structural polyproteins, critical for viral replication [16]. The mechanism is related to the 
3 
 
deprotonation of a thiol group of cysteine at the active site by assistance of an adjacent histidine 
residue [10]. This was confirmed by mutagenesis studies in the nsP2 protease of the Sindbis virus (a 
virus in the same family of CHIKV). The replacement of either cysteine or histidine at its active site 
can completely abolish the proteolytic function [23]. 
 
Although the function and role of the nsP2 protease is well-known, few studies have focused on 
exploring inhibitors for CHIKV targeting this enzyme. Several studies have constructed homology 
models [19, 24, 25] of the nsP2 protease based on the counterparts of the Venezuelan equine 
encephalitis virus (VEEV) to assist in drug design for CHIKV, before a crystal structure of the nsP2 
protease became available in late 2011. With the homology models, inhibitors of the nsP2 enzyme 
have been screened, allowing further compound designs based on pharmacophore models of the 
inhibitors [19, 24, 25]. The active site was predicted in the major surface groove of the C-terminal-
domain region, and likely binds to the substrate polyprotein sequences in the cleavage process [10]. 
The key residues responsible for interactions between the nsP2 protease and ligands were 
established and pharmacophore features of inhibitors were suggested [19]. The structure-activity 
relationships of hit compounds were evaluated with predictions of CHIKV replication inhibition at 
low µM concentrations [25]. Based on the recently reported crystal structure, this current study 
aimed to discover potential new inhibitors of CHIKV nsP2 protease through structure-based 
approaches by combining molecular docking and molecular dynamics simulations. In silico virtual 
screening based on docking was performed to explore inhibitors and potential binding sites of the 
nsP2 protease and predict their binding modes. Furthermore, to understand not only the rigid 
structures but also the dynamic behaviour, molecular dynamics simulations were subsequently 
carried out to provide details of the behaviour of the nsP2 protease and its complexes and their 
flexibilities upon binding of small molecules. The binding free energy for docked structures binding 
to the enzyme was estimated based on the linear interaction energy method.  
 
2. Material and methods 
 
Structure-based virtual screening 
 
Preparation of protein target and ligands: the 3D crystal structure of the nsP2 protease of CHIKV 
was obtained from the Protein Data Bank (PDB id: 3TRK) and served as a protein target in 
docking. The chemical libraries of the National Cancer Institute (NCI) Diversity Set II, which 
contains diverse drug-like compounds, were selected for screening. Before docking, the protein was 
minimized with the steepest-descent algorithm for 3,000 steps using the Accelerys Discovery 
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Studio 2.0 software package with CHARMM force field to relax the structure and remove the steric 
overlap [26]. The minimized structure of protein was then prepared for docking in AutoDock Tools 
(version 1.5.4).  
 
Virtual screening with AutoDock Vina: virtual screening utilized docking with AutoDock Vina 
(version 1.1.2) [27]. The protein was kept rigid while the ligands were fully flexible. The 
Lamarckian Genetic Algorithm was used to search space for docking and the binding affinity of a 
complex was calculated on the basis of a set of weighted energies in empirical-scoring function. 
The key docking parameters were defined including the location of the docking site (centre x, y, z) 
and the size of a grid box. Initially, potential binding sites were detected, based on the blind 
docking in which the box was sufficiently large to cover the whole protein 60 Å × 70 Å × 60 Å 
centred at the centre of protein, or 66 Å × 86 Å × 70 Å centred at centre of a previous reported 
binding site, The next step was a focused docking with a smaller box (20 Å × 20 Å × 20 Å), centred 
on the potential binding site of interest. Additionally, the MetaPocket was used to identify potential 
pocket sites of the nsP2 protease [28]. In total, five potential binding pockets were identified 
including the active site. The top ten compounds were selected according to their binding affinities 
with the default scoring function in Vina. The docking results were analyzed in Accelerys 
Discovery Studio 2.0. The drug-like properties of these compounds were also evaluated using the 
Lipinski Guidelines [29].  
 
Molecular dynamics simulations  
 
The programme NAMD [30] (version 2.9) was used to run molecular dynamics simulations of the 
docked complexes to investigate the stability and flexibility of the nsP2 protease and its complexes 
and to study the detailed interactions between ligands and the nsP2 protease. The protein atoms 
were represented by the CHARMM22 force field [31] and the corresponding parameters for the 
ligands were generated with AmberTools (version 13) [32]. MD simulations were conducted for the 
apo-state (PDB id: 3TRK) and eight complexes of the nsP2 protease and hit compounds were 
obtained from virtual screening. The systems were solvated in a cubic box of TIP3P water 
molecules and neutralized by counterions to achieve the physiological ionic concentration of 0.15 
M with NaCl. All simulations were run under the periodic boundary conditions with the initial 
water box size of 89.7 Å × 89.7 Å × 89.7 Å. The temperature was set at 298.15 K and the pressure 
at 1 atm. The Langevin algorithm was used to maintain the temperature and pressure coupling. The 
Particle Mesh Ewald (PME) algorithm was used to compute long-range electrostatic interactions 
[33]. The cutoff distance for van der Waals interactions was set at 12 Å and the pair-list distance 
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was 13.5 Å. The minimization process was applied first and followed by equilibrium simulations 
with weak harmonic restraints on the heavy atoms for 3 ns. The production runs were continued for 
50 ns. The trajectories for analysis were saved every 10 ps. The resulting trajectories were analyzed 
by the CHARMM [34] and VMD (version 1.9.1) including hydrogen bond and hydrophobic contact 
interactions [35]. 
 
Additional simulations of ligands in water were conducted to calculate the binding free energies 
with the linear interaction energy (LIE, described in the following section). The other parameters 
for MD simulations were the same with simulations for protein as aforementioned. The average 
values of van der Waals and electrostatic contribution were calculated for the equilibrated part of 
the simulations. 
 
Binding free energy calculation from MD simulations 
 
There have been different approaches developed over the years, such as free energy perturbation, 
thermodynamic integration and linear interaction energy (LIE), to calculate the ligand binding free 
energies [36, 37]. In this study, the LIE approach was applied to calculate the absolute binding free 
energies for ligands when complexed with the nsP2 protease. The main reason for this approach 
was that this method effects compromise between speed and accuracy and so it is practically more 
feasible for a large number of ligands. Derived from the linear response theory, the binding free 
energies were approximated as  
∆Gbind= α × <Vbound
vdw  - Vunbound
vdw > + β × <Vbound 
elec - Vunbound
elec > + γ       (1) 
The van der Waals and electrostatic components were obtained from two simulations: one with the 
ligand in an aqueous solution and the other with the nsP2 protease-ligand complex in an aqueous 
solution. The NAMDEnergy plugin in VMD was used to compute the energy components over the 
frames obtained from the MD simulations [30, 35]. In Eq. (1), α, β and γ are empirical parameters 
and can be fitted to the target data. The value α is often set to 0.18 for a wide variety of protein-
ligand systems [37]. The value β represents a function of the chemical nature of the ligand, so in 
principle it can be parameterized from explicit solvent free energy calculations of different chemical 
entities [37]. The value of γ depends on the hydrophobic nature of the binding site [37]. 
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3. Results and discussion 
 
Identification of the active site of the nsP2 protease 
 
It is known that the nsP2 protease carries out its function through a conserved catalytic dyad with a 
cysteine and a histidine, however they have not been conclusively identified in the CHIKV nsP2 
protease. For instance, Bassetto et al. reported that Cys1013 and His1083 (the numbering is 
according to the CHIKV nsP2 sequence) in the homology model of the nsP2 protease were the 
catalytic residues compared to Cys477 and His546 in the VEEV nsP2 protease through a sequence 
alignment between the CHIKV nsP2 protease and the VEEV nsP2 protease. In contrast, similarly 
based the sequence alignment, Singh et al. predicted that the active site residues interacting with the 
peptide substrate include Lys1045, Gly1176, His1222 and Lys1239 without explicitly identifying 
the catalytic residues [19]. In this work, structural alignment of the nsP2 proteases from three 
alphaviruses, CHIKV (PDB id: 3TRK), Venezuelan equine encephalitis virus (VEEV, PDB id: 
2HWK) and Sindbis virus (SINV, PDB id: 4GUA) were carried out with MUSTANG [38] (Figure 
S1). The sequence identity between the CHIKV nsP2 protease sequence and the counterparts in 
VEEV and SINV sequences are 40% and 44%, respectively. This structural alignment revealed that 
Cys1013 and His1083 are the two catalytic residues in the nsP2 protease of CHIKV (Fig. 1). Their 
catalytic roles are supported by their close proximity in the crystal structure. Cys1233 and His1222 
in the C-terminal domain, identified in the homology model by Singh et al., are separated by 15 Å 
in the solved crystal structure (between the S atom in Cys and the N atom in His); thus, they are not 
likely to be the catalytic residues unless there is a structural transition upon substrate binding. 
Conversely, Cys1013 and His1083 in the N-terminal domain are sufficiently close enough to carry 
out proton transfer (with the distance of 4.8 Å between the S atom in Cys1013 and the N atom in 
His1083); thus, they are properly positioned to be a catalytic dyad. In addition, the presence of 
Trp1084 close to His1083 was proposed to be necessary for a functional protease [39].  
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Figure 1. Superimposition of three crystal structures, namely the CHIKV nsP2 protease (PDB id: 
3TRK, in blue), the VEEV nsP2 protease (PDB id: 2HWK, in red) and the structure of SINV (PDB 
id: 4GUA, in grey). The conserved catalytic residues, cysteine and histidine (in licorice, Cys1013 
and His1083 in the CHIKV nsP2 protease (in blue), Cys477 and His546 in the VEEV nsP2 protease 
(in red) and Cys1021 and His1098 in the SINV structure (in grey)) are also shown.  
 
Blind dockings and focused dockings to identify potential binding sites and hit compounds for 
the nsP2 protease 
 
In order to identify potential inhibitors targeting the nsP2 protease, blind dockings were initially 
carried out to discover potential binding sites of the nsP2 protease and potent inhibitors. The 
compounds from library NCI Diversity Set II were docked to the entire protein (the nsP2 protease) 
with a grid box placed at either the centre at the binding site 1 (VST1) or at the centre of the protein 
(VST2). The binding site 1 (Pocket 1), including the key residues for interactions (Lys1045, 
Gly1176, His1222 and Lys1239), was taken from the published data by Singh et al [19]. The 
binding modes of the compounds were ranked by their predicted binding affinities. The top ten 
compounds (hit compounds) for each virtual screening (VST), are listed in Table 1 (their chemical 
structures was listed in Table S1) with their binding affinities and the locations. 
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Table 1. Results of the top ten hit compounds from the blind dockings. The binding affinities ΔG 
are in kcal/mol.  
VST1
a
 VST2
b
 
Hits  ΔG  Location Hits ΔG Location 
1. NCI_61610  -10.6 Pocket 1 1. NCI_293778 -10.3 Pocket 4 
2. NCI_293778 -10.3 Pocket 4 2. NCI_61610 -10.1 Pocket 1 
3. NCI_116702 -9.2 Pocket 3 3. NCI_670283  -9.7 Pocket 4 
4. NCI_37553 -9.2 Pocket 4 4. NCI_116702  -9.2 Pocket 3 
5. NCI_84100_a -9.2 Pocket 3 5. NCI_217697 -9.2 Pocket 1 
6. NCI_84100_b -9.1 Pocket 3 6. NCI_84100_a -9.2 Pocket 1 
7. NCI_25457  -9.0 Pocket 3 7. NCI_84100_b -9.2 Pocket 1 
8. NCI_670283 -9.0 Pocket 1 8. NCI_298892_b -9.1 Pocket 1 
9. NCI_97920 -9.0 Pocket 3 9. NCI_37553 -9.1 Pocket 5 
10. NCI_58052 -8.8 Pocket 3 10. NCI_25457 -9.0 Pocket 3 
 
a) In VST1, the grid box is centred at Pocket 1 of the nsP2 protease (12.4 Å, 34.3 Å, 28.6 Å) with 
dimensions of 66 Å × 86 Å × 60 Å. b) In VST2, the grid box is centred at the centre of the nsP2 
protease (14.3 Å, 25.5 Å, 22.3 Å) with dimensions of 60 Å × 70 Å × 60 Å. The origin and axes of 
the coordinate systems were set the same as in the PDB structure (PDB id: 3TRK). 
 
Additionally, the potential binding pockets were predicted with the MetaPocket algorithm. In total, 
there were five potential binding pockets (labelled as Pockets 1-5, shown in Fig. 2) identified for 
the nsP2 protease. Pocket 4, containing the catalytic dyad Cys1013 and His1083, is the active site. 
The blind docking data initially revealed four potential binding sites in the nsP2 protease (Pockets 
1, 3, 4, 5) where the hit compounds could potentially bind. In the docking VST1, six out of ten 
ligands preferred binding at Pocket 3 along with two ligands at Pocket 1 and two ligands at Pocket 
4. In VST2, most of the ligands (five) occupied Pocket 1, two ligands occupied Pocket 3, two 
ligands occupied Pocket 4 and one ligand occupied Pocket 5. Encouragingly, the four binding 
pockets identified in the blind docking were reproduced by the MetaPocket method, despite the 
methods being based on very different algorithms. Additionally, a further pocket (Pocket 2) near 
Pocket 1 was found. Pocket 1 and Pocket 4 (Fig. 2: behind) were groove-like while Pocket 2 
(adjacent to Pocket 1, sharing some residues with Pocket 1 such as Tyr1177 and His1222), Pocket 3 
(behind) and Pocket 5 (behind) were shallow. Pocket 3 was below Pocket 1, Pocket 4 was on the 
opposite site behind Pocket 1 and Pocket 5 was in the rear side behind Pocket 1. The binding 
affinities of all hit compounds were approximately -9 kcal/mol, which indicates favourable 
interactions between the compounds and the nsP2 protease. It was also interesting to note that some 
compounds could bind into different pockets with varying conformations such as NCI_670283 
(Pocket 1 and 4), NCI_84100_b (Pocket 1 and 3) and NCI_37553 (Pocket 3 and 5).  
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In an effort to obtain more hit compounds for the nsP2 protease as well as to eliminate potential 
sampling issues with the blind docking, a focused docking centred at each of the potential pockets 
identified with the blind docking and MetaPocket method was carried out. The VST3/VST4, VST5, 
VST6, VST7 and VST8 screenings were focused at Pocket 1, Pocket 2, Pocket 3, Pocket 4 and 
Pocket 5, respectively. The results of the top ten compounds and their binding affinities are listed in 
Table S2 and their chemical structures are presented in Table S3. The top docked structures of each 
virtual screening are represented in Fig. 2, showing the locations of five pockets (more details are 
illustrated in Fig. S2 with hit compounds at each of focused dockings and in Fig. S3 with top hit 
compounds and surrounding residues within 5 Å of each pocket). 
 
Figure 2. Representation of docked structures of top hit compounds in different virtual screenings at 
five different binding sites of the nsP2 protease with Pocket 4 being the active site of the nsP2 
protease. 
 
Interestingly, a change of grid box size and its location affected the searching process in the Vina 
program. In VST4 with an increased box size, larger compounds were identified as top hits despite 
not being present in VST3 for example NCI_293778 (-9.8 kcal/mol), NCI_84100_a (-9.2 kcal/mol) 
and NCI_84100_b (-9.2 kcal/mol). It is likely that the larger grid box accommodates the binding of 
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these molecules better. Some hit compounds were present in different virtual screenings, such as 
NCI_293778 (Pocket 1-5), NCI_37553 (Pocket 1-5) and NCI_61610 (Pocket 1, 4 and 5).  
 
Binding modes obtained from docking at potential binding sites were analyzed to show details of 
interactions and to identify key residues through analyses of hydrogen bonds (H-bonds) or 
hydrophobic contacts. The residues surrounding ligands within 5 Å which make up each pocket are 
presented in Table 2. As mentioned earlier, the active site was Pocket 4 with Cys1013 and His1083 
in good positions to be a catalytic dyad. The residue Trp1084 is close to His1083 in Pocket 4 which 
is essential for interactions, as previously reported in the study of the nsP2 protease of SINV [23]. 
The results of the focused dockings showing the important residues involved in forming H-bonds 
and hydrophobic contact for each pocket, are listed in Table 2. Among the five pockets, with 
respect to ligands containing aromatic rings, π-stacking interactions and π-network interactions 
were often present with His1222 at Pocket 1, Tyr1177 at Pocket 2 and Tyr1079 at Pocket 4.  
 
Table 2. The important residues in each pocket of the nsP2 protease with the key residues involved 
in forming H-bonds and hydrophobic contacts between the protein and ligands in bold. 
Binding pocket Residues making up the pocket 
Pocket 1 Gln1039, Ala1040, Glu1043, Lys1045, Ala1046, Tyr1047, Gly1176, 
Tyr1177, Pro1191, Leu1192, Gly1193, Val1194, Asn1202, Leu1203, 
Glu1204, Ile1221, His1222, Thr1223, Asp1235, His1236, Met1238, 
Lys1239, Met1242 and Cys1233 
Pocket 2 His1151, Pro1153, Val1154, Lys1155, Gly1156, Glu1157, Arg1158, 
Met1159, Glu1160, Tyr1177, Asn1178, Leu1179, Ala1180, His1222, 
Thr1223, Pro1224, Phe1225, Gln1232, Arg1260, Tyr1262, Ser1293, 
Thr1292 and Thr1295 
Pocket 3 Glu1157, Arg1158, Met1159, Trp1161, Leu1162, Lys1165, Ile1166, 
Asn1167, Gly1254, Ser1256, Arg1281, Ser1282, Arg1284, Leu1286, 
Lys1287, Pro1288, Pro1289, Cys1290, Leu1300, Ser1302 and Asn1303 
Pocket 4 Cys1013, Ala1046, Tyr1047, Ser1048, Pro1049, Glu1050, Val1051, 
Tyr1078, Tyr1079, Asn1082, His1083, Trp1084, Gly1090, Lys1091, 
Phe1093, Tyr1201, Asn1202, Glu1204, Leu1205, Gly1206, Pro1208, 
Ala1209, Met1238, Gln1241, Met1242, Gly1245,  Asp1246 and Arg1249 
Pocket 5 Asn1040, Glu1050, Leu1053, Asp1064, Leu1065, Asp1066, Ser1067, 
Gly1068, Leu1069, Phe1070, Ser1071, Lys1091, Phe1093, Asn1096, 
Glu1098, Ala1099, Ile1102, Leu1103, Lys1106, Tyr1107, Asn1140, 
Arg1141, Arg1142, Leu1143, Pro1144, Arg1267, Glu1270, Arg1271, 
Cys1274, Val1275, Arg1278, Thr1313, His1314 and Asn1317 
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Molecular dynamics simulations investigating the stability of the protein and its complexes  
  
The top hit compounds NCI_217697, NCI_61610, NCI_37553 and NCI_293778 from virtual 
screenings were subjected to molecular dynamics simulations using the NAMD package (Table 3). 
In particular, ligand NCI_293778 with different conformations at the different binding sites 
(NCI_293778vst4 at Pocket 1, NCI_293778vst5 at Pocket 2, NCI_293778vst2 and 
NCI_293778vst7 at Pocket 4 and NCI_293778vst8 at Pocket 5) was investigated.  
 
Table 3. Chemical structure of five top hit compounds and their properties. 
 Compound Structural formula ΔG
a
 Physical 
properies 
1 NCI_61610 
(C34H24N6O2) 
 
 
-10.6 
 
LogP
b
: 5.31 
H-D
c
: 4 
H-A
d
: 4 
MW
e
: 548.6 
2 NCI_217697 
(C25H30N2) 
 
 
-9.3 
 
LogP: 4.97 
H-D: 2 
H-A: 0 
MW: 358.5 
3 NCI_293778 
(C40H26N4S) 
 
-9.8
f
,  
-10.4
g
 
and  
-10.2
h 
 
LogP: 10.87 
H-D: 0 
H-A: 4 
MW: 594.73 
4 NCI_37553 
(C30H28N4O2) 
 
 
-9.6 
 
LogP: 5.03 
H-D: 2 
H-A: 2 
MW: 476.57 
 
 
O
N
H
N
H
O
NNH
N
N
H
 
N N
H H
 
N
N
S
N
N
 
N N
O
H
N N
H
O
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a) ΔG refers to the binding affinities by Vina in kcal/mol. b) The logarithm of the partition 
coefficient between n-octanol and water using ChemBioDraw Ultra 14.0. c) Number of hydrogen 
bond donor atoms. d) Number of hydrogen bond acceptor atoms. e) Molecular weight. f) Located in 
Pocket 1 and Pocket 2. g) Located in Pocket 4. h) Located in Pocket 5. 
 
The overall stability of the nsP2 protease and its complexes was evaluated by the values of 
backbone atomic positional root-mean-square-deviation (RMSDs). Analysis of the backbone 
RMSD profile (Fig. S4) showed that most of the systems were stable during the simulations within 
1-2 Å after reaching equilibrium within 50 ns. In simulation of the complex of ligand 
NCI_293778vst8 at Pocket 5, a large RMSD was observed around 47 ns (Fig. S4). Examination of 
the structures revealed that it was due to the relative movement between two domains and the 
fluctuation of loops. This ligand was also found to gradually move from a position whereby part of 
the ligand was positioned out of the pocket, to the whole ligand being out of the pocket but still 
stuck at the rear after 40 ns and finally dissociated from the pocket after 47 ns. 
 
The trajectories after 3 ns were used for further analysis. For the flexibility of the nsP2 protease and 
its complexes, the root-mean-square-fluctuation (RMSF) curves of the Cα atoms in the nsP2 
protease and its complexes were calculated (Fig. 3). Comparative analysis of the RMSF values of 
the apo protein and the complexes was focused on the binding sites of ligands. Most of the residues 
making up the binding sites were quite stable during the simulation with fluctuations within 2 Å. 
Furthermore, no significantly reduced fluctuations were found in the binding pockets of the protein 
in comparison with the nsP2 protease (apo protein) and its complexes of the nsP2 protease-ligand.  
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Figure 3. RMSFs values of Cα atoms of the apo protein nsP2 and its different complexes during MD 
simulations. 
 
Atomic details of interaction between the nsP2 protein and hit compounds 
 
More details were obtained by analysis of the molecular interactions between the ligands and nsP2 
through hydrogen bonding interactions and hydrophobic contacts. The criterion for a hydrogen 
bond in a given structure was a maximum distance of 3.5 Å between hydrogen donor (D) and 
acceptor (A) atoms and the angle D-H…A must be greater than 120° [17]. A cutoff distance of 4.0 
Å was used in monitoring hydrophobic contacts between the non-polar parts of residues of the nsP2 
protease and ligands [40, 41]. For most of the investigated hit compounds, their interactions with 
the nsP2 protease were from hydrophobic contacts rather than H-bonds, as most of the H-bonds 
occupancy was found to be low (less than 10%).  The residues involved in forming hydrophobic 
contacts based on the trajectories of the MD simulations are listed in Table 4 and H-bonds 
occupancies are listed in Table S4. 
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Table 4. Hydrophobic contact analyses on the trajectories sampled in the MD simulations. 
 
Ligand Interacting non-polar parts of the residues  
NCI_61610 Ala1040, Tyr1177, Pro1191, Leu1203, Ile1221, Leu1243 
NCI_217697 Pro1191, Leu1243 
NCI_37553 Trp1161, Leu1162, Leu1286, Pro1288, Pro1289, Leu1300 
NCI_293778vst4 Pro1191, Leu1192, Leu1203, Ile1221, Leu1243 
NCI_293778vst5 Tyr1177, Pro1224 
NCI_293778vst2 Ala1046, Tyr1079, Trp1084, Leu1205 
NCI_293778vst7 Ala1046, Val1077, Tyr1079, Trp1084, Leu1205 
NCI_293778vst8 Ile1102, Leu1103 
 
 
Considering the structure of the ligands, the presence of both donor and acceptor atoms in the 
ligand NCI_61610 and NCI_37553 could form more H-bonds than ligands NCI_217697 and 
NCI_293778. As expected, H-bonds were mostly formed with NCI_61610 and NCI_37553. Ligand 
NCI_61610 showed H-bond interactions with residues Lys1239, Glu1204, Leu1203, Tyr1177, 
Gly1176 and Lys1045, although these interactions were weak (their occupancies less than 10%). 
The complex nsP2 protease-ligand NCI_37553 at Pocket 3 was maintained through strong H-bonds 
between its oxygen and with Arg1284 (80.5%), or between its nitrogen and Arg1284 (26.3%), or 
this oxygen with Ser1302 (10.4%). Interestingly, a comparison of NCI_293778 bound at different 
binding sites revealed that the nitrogen of this ligand could form one H-bond (with an occupancy of 
10.7%) with residue His1222 at Pocket 1 accompanied by surrounding hydrophobic interactions 
(Fig. 4) but in contrast, NCI_293778 did not often have strong H-bonds at other pockets (with low 
occupancies, see Table S4). This indicates that NCI_293778vst4 was more likely to be 
accommodated in Pocket 1 than in other pockets. However, the aromatic ring of this ligand could 
form π-stacking interactions or a π-network with Tyr1177 (Pocket 2) and Tyr1079, Trp1084 
(Pocket 4) to maintain the interactions between the protein nsP2 protease and ligand. 
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Figure 4. The docked structure of ligand NCI_293778vst4 (in green) in Pocket 1 showing the 
residues forming Pocket 1 and the compound-protein interactions (in grey). 
 
Furthermore, the interaction between these ligands and nsP2 at the different binding sites was 
examined to compare with docking and simulation results. The docking results were in close 
agreement with molecular dynamics simulations even though in order to maintain interactions there 
was flexibility of residues in the protein and ligands in forming H-bonds or creating hydrophobic 
contacts during simulations. There was no major change in the important residues at the binding 
sites of the nsP2 protease. Moreover, understanding the effects of ligand binding to other binding 
pockets on the active site was also of interest. The comparison of the initial and final structures in 
MD simulations revealed no significant structural changes in the residues in the active site. 
Experimental validation is required to confirm whether there was an allosteric site or a synergistic 
effect upon binding at different sites within the active site of the nsP2 protease. 
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Binding free energy calculations using the linear interaction energy (LIE) method 
 
The prediction of binding free energy is usually a challenge for docking and scoring in 
computational drug design. In this study, the converged trajectories of complexes obtained from 
simulations were used to calculate the binding free energy for the hit compounds. The average 
values of van der Waals and electrostatic interactions for each ligand in the two states (bound state 
and unbound state) were calculated (Table 3). The van der Waals value of the ligands in the 
complex with the enzyme were much more negative than when only in solution, showing that the 
ligand has more favorable van der Waals interactions in the complex. However, it is striking that 
the electrostatic interactions of ligands in all the complexes were significantly less favourable than 
those of the ligand in water. In applying the LIE equation, the values of empirical parameters α, β 
and γ require an understanding of the chemical structure and also the binding site [37]. For the 
value of β, all of the top hit compounds in the study are neutral compounds and this value was 
estimated to be β = 0.43, based the empirical function proposed previously [37]. Initially, the test 
value of α and γ were set 0.18 and 0.0, respectively, which did not agree with the docking results 
(ΔG1 in Table 3). However, as it has been shown that α and γ need to be recalibrated depending on 
the different systems; the α value has been suggested to be dependent on the system and the force 
field used in the LIE calculations while the γ relies on the nature of the binding site. In this case, 
due to the lack of experimental data of complexes, the chemical nature of the ligands and the 
binding sites were taken into the consideration. Most binding sites are composed of both polar and 
non-polar residues, so the definition of hydrophobicity in the selection of γ is not easy to define and 
in practice, the exact value of γ does not affect the relative ranking. A larger value of α = 1.043 was 
adopted as it had been shown to provide a better estimate in the study of cytochrome P450-camphor 
analogue complexes [42]. The results of ΔG2 with α set to 1.043 are shown in Table 3 and revealed 
better agreement with the binding affinity obtained from docking. This gave good explanations 
when comparing the binding free energies for different ligands at the same pocket, such as in the 
case of NCI_61610, NCI_217697 and NCI_293778vst4. For instance, ligand NCI_293778vst4 with 
the presence of stronger H-bonds (indicated by the higher value of H-bond occupancy) had higher 
binding affinities compared to the other ligands. H-bonds and hydrophobic contacts in some ligands 
(such as NCI_293778vst4 and NCI_37553) were maintained. These ligands were expected to gain 
lower binding free energies, however LIE predictions did not show this. It could be explained that 
there was a compromise between van der Waals and electrostatic results from hydrogen bonds 
interactions and hydrophobic contacts between the ligands and the enzyme nsP2 protease that 
contributes to the binding free energy. More work and results from experimental data are required 
to clarify the issue. 
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Table 3. Average binding free energies (kcal/mol) of top hit compounds calculated by LIE method 
using data trajectories from the MD simulations: ΔG1 (in kcal/mol using α = 0.18, β = 0.43 and γ = 0) 
or ΔG2 (in kcal/mol using α = 1.043, β = 0.43 and γ = 0) [37]. ΔG is the predicted binding affinity by 
Vina (in kcal/mol) 
Hit compound 𝐕𝐛𝐨𝐮𝐧𝐝
𝐯𝐝𝐰   𝐕𝐮𝐧𝐛𝐨𝐮𝐧𝐝
𝐯𝐝𝐰  𝐕𝐛𝐨𝐮𝐧𝐝
𝐞𝐥𝐞𝐜  𝐕𝐮𝐧𝐛𝐨𝐮𝐧𝐝
𝐞𝐥𝐞𝐜  ΔvdW ΔElec ΔG
1
 
 
ΔG
2
 
 
ΔG 
NCI_61610 -65.0 -54.4 -79.2 -91.0 -10.6 11.8 3.2 -6.0 -10.6 
NCI_217697 -50.0 -39.1 -30.4 -36.2 -10.9 5.8 0.5 -8.9 -9.3 
NCI_37553 -60.1 -48.6 -62.5 -73.1 -11.5 10.6 2.5 -7.4 -9.6 
NCI_293778vst4 -69.6 -54.6 -35.6 -48.0 -15.0 12.4 2.6 -10.3 -9.8 
NCI_293778vst5 -68.5 -54.4 -42.3 -47.8 -14.1 5.5 -0.2 -12.3 -9.8 
NCI_293778vst2 -69.2 -54.7 -38.9 -47.7 -14.5 8.8 1.1 -11.3 -10.3 
NCI_293778vst7 -72.7 -55.6 -40.9 -48.2 -17.1 7.3 0.1 -14.6 -10.4 
NCI_293778vst8 -65.6 -54.4 -43.2 -47.4 -11.2 4.2 -0.2 -9.9 -10.2 
 
 
4. Conclusion 
 
In this work, the X-ray crystal structure of nsP2 protease was utilized to conduct a combination of 
molecular docking, virtual screening and molecular dynamics simulations to search for potential 
inhibitors of the nsP2 protease. Starting with blind dockings and published information, we 
identified top hit compounds, together with the five potential binding pockets of the nsP2 protease. 
Subsequently, the focused dockings into these different binding sites were investigated to discover 
more hit compounds and look at further binding modes at these pockets. The top hit compounds 
were then subjected to molecular dynamics simulations for 50 ns after equilibration. The simulation 
results demonstrated the different binding affinities of different ligands through the number of H-
bonds and hydrophobic contacts. Previous studies largely focused on Pocket 1 as the active site. 
However, in this study, Pocket 4 in the N-terminal domain of the nsP2 protease was identified as 
the active site by the presence of catalytic residues, Cys1013 and His1083. Importantly, the current 
work offers more opportunities to identify potential inhibitors. The effect upon the active site of 
ligands binding into different pockets requires further experimental work. Finally, the trajectories 
data of MD simulations were utilized for the linear interaction energy to obtain accurate binding 
free energy. The suggestion of increasing the value of α from 0.18 to 1.043 provided more reliable 
results. More experimental data is required to elucidate the issue in regard to achieving compromise 
between van der Waal and electrostatic energy. Finally, it is worth emphasizing that this is the first 
instance where molecular modelling with more accurate data from X-ray structure has been studied. 
Our findings open up a promising approach in combining docking and molecular dynamics 
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simulations to assist in rational drug design, especially providing useful information for the design 
of inhibitors for CHIKV that can help to combat the disease. 
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                               * 
3TRK.pdb          1  N-AFQNKANVCWAKSLVPILETAGIKLNDRQWSQIIQAFKEDKAYSPEVALNEICTR-YG   58 
2HWK.pdb          1  -DVFQNKANVCWAKALVPVLKTAGIDMTTEQWN-TVDYFETDKAHSAEIVLNQLCVRFFG   58 
4GUA.pdb          1  -NPFSCKTNVCWAKALEPILATAGIVLTGCQWSELFPQFADDKPHSAIYALDVICIKFFG   59 
                        FqnKaNVCWAKaLvPiL TAGI lt          F DKa hSa eaL niC r fG 
 
                                                * 
3TRK.pdb         59  VDLDSGLFSKPLVSVYYAD-------NHWDNRPG-GKFGFNPEAASILERKYPFTKGKWN  110 
2HWK.pdb         59  LDLDSGLFSAPTVPLSIRN-------NHWDNSPSPNMYGLNKEVVRQLSRRYPQLPRAVA  111 
4GUA.pdb         60  MDLTSGLFSKQSIPLTYHPADSARPVAHWDNSPGTRKYGYDHAIAAELSRRFPVFQ-LAG  118 
                      DLdSGLFSkp vpl y         nHWDNsPg  kyG n e a  LsRryP 
 
3TRK.pdb        111  INKQICVTTRRIEDFNPTTNIIPVNRRLPHSLVAEHRPVKG-EREWLVNKINGHHVLLVS  169 
2HWK.pdb        112  TGRVYDMNTGTLRNYDPRINLVPVNRRLPHALVLHHNEHPQSDFSSFVSKLKGRTVLVVG  171 
4GUA.pdb        119  KGTQLDLQTGRTRVISAQHNLVPVNRNLPHALVPEYKEKQPGPVKKFLNQFKHHSVLVVS  178 
                      g q d  Tgr r   p  NlvPVNRrLPHaLV eh e        fvnk kgh VLvVs 
 
3TRK.pdb        170  GYNLALPTKRVTWVAPLGVRGADYTYNLELGLPATLGRYDLVVINIHTPFRIHHYQQCVD  229 
2HWK.pdb        172  E-KLSVPGKMVDWLS--DRPEATFRARLDLGIPGDVPKYDIIFVNVRTPYKYHHYQQCED  228 
4GUA.pdb        179  EEKIEAPRKRIEWIAPIGIAGADKNYNLAFGFPP-QARYDLVFINIGTKYRNHHFQQCED  237 
                      ekl  P Krv W a  g  gAdyn  Ll G P    rYDlvfiNi TpyrHHy QQCeD 
 
3TRK.pdb        230  HA-KL-QLGGDSLRLLKPGGSLLIRAYGYADRTSERVICVLGRKFRSSRALKPPCVTSNT  287 
2HWK.pdb        229  HAIKLSMLTKKACLHLNPGGTCVSIGYGYADRASESIIGAIARQFKFSRVCKPKSSLEET  288 
4GUA.pdb        238  HAATLKTLSRSALNCLNPGGTLVVKSYGYADRNSEDVVTALARKFVRVSAARPDCVSSNT  297 
                     HA kL  L   al  LnPGGtlv   YGYADR SE vi alaRkF   srakP cv snT 
 
3TRK.pdb        288  E-FFLFSNFDNGR-RNFTTH-VNNQLNAAF------------------------------  314 
2HWK.pdb        289  EVLFVFIGYDRKART-HNPYKLSSTLTNIYTGS---------------------------  320 
4GUA.pdb        298  EMYLIFRQLDNSRTRQFTPHHLNCVISSVYEGTRDGVGAAPSYRTKRENIADCQEEAVVN  357 
                     E   fF   Dn r  rftph ln  l   y                               
 
3TRK.pdb             ------------------------------------------------------------      
2HWK.pdb             ------------------------------------------------------------      
4GUA.pdb        358  AANPLGRPGEGVCRAIYKRWPTSFTDSATETGTARMTVCLGKKVIHAVGPDFRKHPEAEA  417 
 
 
3TRK.pdb             ------------------------------------------------------------      
2HWK.pdb             ------------------------------------------------------------      
4GUA.pdb        418  LKLLQNAYHAVADLVNEHNIKSVAIPLLSTGIYAAGKDRLEVSLNCLTTALDRTDADVTI  477 
 
 
3TRK.pdb             ------------------------------------------------------------      
2HWK.pdb             ------------------------------------------------------------      
4GUA.pdb        478  YCLDKKWKERIDAALQLKESVTELKDEDMEIDDELVWIHPDSCLKGRKGFSTTKGKLYSY  537 
 
 
3TRK.pdb             ------------------------------------------------------------      
2HWK.pdb             ------------------------------------------------------------      
4GUA.pdb        538  FEGTKFHQAAKDMAEIKVLFPNDQESNEQLCAYILGETMEAIREKCPVDHNPSSSPPKTL  597 
 
 
3TRK.pdb                ------------------------------------------------------------      
2HWK.pdb                ------------------------------------------------------------      
4GUA.pdb           598  PCLCMYAMTPERVHRLRSNNVKEVTVCSSTPLPKHKIKNVQKVQCTKVVLFNPHTPAFVP  657 
 
 
3TRK.pdb                -----      
2HWK.pdb                -----      
4GUA.pdb           658  ARKYI  662 
 
 
Figure S1. Sequences alignment of three crystal structures, namely the nsP2 protease of CHIKV 
(PDB id: 3TRK), the nsP2 protease of VEEV (PDB id: 2HWK) and the nsP2 protein of SINV (PDB 
id: 4GUA). The catalytic cysteine and histidine are highlighted with *. 
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Figure S2. Structure of the nsP2 protease with top hit compounds showing location of the binding 
sites at the different virtual screenings: (A) VST3; (B) VST4; (C) VST5; (D) VST6; (E) VST7; (F) 
VST8. 
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Figure S3. Representation of top docked structures in different virtual screenings into two pictures, 
one with the ligand (in blue stick) bound in the protein nsP2 (in purple ribbon) and another with the 
ligand and its surrounding residues: A. NCI_217697 at Pocket 1 in VST3; B. NCI_293778 at 
Pocket 1 in VST4; C. NCI_61610 at Pocket 1 in VST1; D. NCI_293778 at Pocket 4 in VST2; E. 
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NCI_293778vst5 at Pocket 2 in VST5; F. NCI_37553 at Pocket 3 in VST6; G. NCI_293778vst7 at 
Pocket 4 in VST7; H. NCI_293778vst8 at Pocket 5 in VST8. 
 
 
Figure S4. The backbone RMSD profiles for the apo protein nsP2 and its different complexes 
during MD simulations. 
 
 
 
Table S1. Chemical structure for top hit compounds in blind dockings. 
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Table S2. Results of the top ten compounds of focused dockings. The binding affinities are in 
kcal/mol. 
 
a) VST3, the grid box is centred at Pocket 1 (12.4 Å, 34.3 Å, 28.6 Å) with a dimension of 16 Å × 
16 Å × 16 Å. b) In VST4, the grid box is centered at Pocket 1 (12.4 Å, 34.3 Å, 28.6 Å) with a 
dimension of 20 Å × 20 Å × 20 Å. c) In VST5, the grid box is centered at Pocket 2 (28.1 Å, 36.9 Å, 
30.6 Å) with a dimension of 20 Å × 20 Å × 20 Å. d) In VST6, the grid box is centered at Pocket 3 
(30.4 Å, 42.1 Å, 14.8 Å) with a dimension of 20 Å × 20 Å × 20 Å. e) In VST7, the grid box is 
centered at Pocket 4 (3.2 Å, 31.9 Å, 18.1 Å) with a dimension of 20 Å × 20 Å × 20 Å. f) In VST8, 
the grid box is centered at Pocket 5 (15.2 Å, 13.9 Å, 11.5 Å) with a dimension of 20 Å × 20 Å × 20 
Å. 
 
Table S3. Chemical structure for top hit compounds in all of screenings. 
 
NCI_217697 
 
 
NCI_670283 
 
 
 
N N
H H  O
O
VST3
a
 VST4
b
 VST5
c
 VST6
d
 VST7
e
 VST8
f
 
1.NCI_217697 
(-9.3) 
2.NCI_670283 
 (-9.3) 
3.NCI_298892_b  
(-9.2) 
4.NCI_328101 
(-9.2) 
5.NCI_25457  
(-9.1) 
6.NCI_116702  
(-9.0) 
7.NCI_80997_a 
(-9.0) 
8.NCI_109451  
(-8.9) 
9.NCI_93427  
(-8.9) 
10.NCI_127133 
 (-8.8) 
   
1.NCI_293778 
 (-9.8) 
2.NCI_37553  
(-9.7) 
3.NCI_328101 
(-9.3) 
4.NCI_670283  
(-9.3) 
5.NCI_25457  
(-9.2) 
6.NCI_298892_b  
(-9.2) 
7.NCI_61610  
(-9.2)  
8.NCI_84100_a  
(-9.2) 
9.NCI_84100_b  
(-9.2)  
10.NCI_217697 
(-9.1) 
1.NCI_293778 
 (-9.8) 
2.NCI_37553  
(-9.4) 
3.NCI_269148_a 
 (-8.5) 
4.NCI_146771 
 (-8.3) 
5.NCI_227186_b 
 (-8.3) 
6.NCI_308835 
 (-8.3) 
7.NCI_7524_b 
(-8.3)  
8.NCI_227186_a 
 (-8.2) 
9.NCI_328101 
(-8.2) 
10.NCI_362639 
(-8.2) 
1.NCI_37553  
(-9.6) 
2.NCI_319990  
(-9.4) 
3.NCI_116702 
 (-9.2) 
4.NCI_61610 
(-9.2) 
5.NCI_25457  
(-9.0) 
6.NCI_293778  
(-9.0) 
7.NCI_97920 
 (-9.0)  
8.NCI_67436 
(-8.9)  
9.NCI_80997_b  
(-8.9) 
10.NCI_84100_b 
(-8.9) 
1.NCI_293778 
(-10.4) 
2.NCI_670283  
(-9.7) 
3.NCI_121868_a 
 (-9.3) 
4.NCI_37553 
(-9.2) 
5.NCI_61610  
(-9.2) 
6.NCI_319990  
(-8.9) 
7.NCI_328101 
 (-8.9)  
8.NCI_67436 
(-8.9)  
9.NCI_227186_a  
(-8.8) 
10.NCI_122819_b 
(-8.7) 
1.NCI_293778 
(-10.2) 
2.NCI_80734 
(-9.2) 
3.NCI_61610 
 (-9.1) 
4.NCI_37553 
(-9.0) 
5.NCI_80735  
(-8.7) 
6.NCI_80997_a  
(-8.4) 
7.NCI_345845 
 (-8.1)  
8.NCI_5157 
(-8.1)  
9.NCI_58052  
(-8.1) 
10.NCI_67436 
(-8.1) 
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Table S4. Hydrogen bonding analyses on the trajectories sampled in the MD simulations.  
Ligands Details of H-bonds % occupancy 
NCI_61610 
 
Lys1239(HZ1)-N1 7.5 
Lys1239(HZ2)-N1 6.0 
Lys1239(HZ3)-N1 5.6 
His1222(HN)-O1 4.5 
Glu1204(HN)-O 3.1 
Lys1239(HZ3)-O  2.9 
Lys1239(HZ2)-O  2.7 
Lys1239(HZ1)-O      2.6 
His1222(HN)-O      1.8 
Lys1045(HZ3)-N1     0.3 
Lys1045(HZ1)-N1      0.3 
Lys1045(HZ2)-N1     0.3 
Lys1045(HZ2)-O 0.1 
Lys1045(HZ3)-O 0.1 
Gly1176(HN)-O1     0.1 
NCI_217697 
 
Gln1039(OE1)-H 0.2 
Glu1043(OE2)-H 0.1 
Leu1193(O)-H1 1.7 
Asn1202(OD1)-H1 0.3 
Glu1204(OE1)-H 0.5 
Glu1204(O21)-H 0.4 
NCI_37553 
 
Arg1284(HH12)-O1 80.5 
Arg1284(HH12)-N1 26.3 
Ser1302(HG1)-O1 10.4 
Lys1165(HZ2)-O 7.2 
Lys1165(HZ1)-O 2.9 
Lys1165(O)-H1 1.7 
 
NCI_293778vst4 
 
His1222(HD1)-N3     10.7 
Asn1202(HD21)-N3     0.5 
Lys1239(HZ1)-N  0.1 
Lys1239(HZ2)-N 0.1 
Lys1239(HZ3)-N 0.1 
Lys1045(HZ2)-N3      0.1 
Lys1045(HZ3)-N3      0.1 
Leu1192(HN)-N2      0.1 
NCI_293778vst5 
 
 
Gly1156(HN)-N      1.4 
Lys1155(HZ2)-N       0.8 
Lys1155(HZ1)-N     0.5 
Lys1155(HZ3)-N      0.5 
Met1159(HN)-N      0.1 
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NCI_293778vst2 
 
 
Tyr1079(HH)-N3     8.6 
Asn1082(HD22)-N2     5.8 
Asn1082(HD22)-N3     5.8 
Trp1084(HE1)-N3     3.4 
Asn1082(HD21)-N3     3.6 
Asn1082(HD21)-N2     0.4 
Tyr1079(HN)-N1     0.2 
Leu1207(HN)-N2     0.1 
NCI_293778vst7 
 
 
Ser1048(HG1)-N2 0.6 
Tyr1079(HH)-N 0.1 
Asn1082(HD21)-N1 0.1 
Asn1082(HD22)-N 0.1 
NCI_293778vst8 
 
Ser1067(HG1)-N2 0.2 
Arg1105(HE)—N3 0.2 
Arg1105(HH11)-N 0.1 
Lys1106(HZ2)-N2 0.1 
Lys1106(HZ3)-N2 0.1 
Arg1141(HH11)-N3 0.1 
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